MedPath
HSA Approval

MENDICOF SYRUP (Revised Formula)

SIN11516P

MENDICOF SYRUP (Revised Formula)

MENDICOF SYRUP (Revised Formula)

May 15, 2001

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05DA20

combinations

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

DEXTROMETHORPHAN HBr

15 mg/5 ml

Dextromethorphan

PSEUDOEPHEDRINE HCl

30 mg/5 ml

Pseudoephedrine

DEXCHLORPHENIRAMINE MALEATE

2 mg/5 ml

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MENDICOF SYRUP (Revised Formula) - HSA Approval | MedPath